Back to Search
Start Over
Novel third-generation tyrosine kinase inhibitor for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a case study
- Source :
- Anti-Cancer Drugs. 34:599-604
- Publication Year :
- 2022
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2022.
- Subjects :
- Pharmacology
Cancer Research
Oncology
Pharmacology (medical)
Subjects
Details
- ISSN :
- 09594973
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Anti-Cancer Drugs
- Accession number :
- edsair.doi...........7c1b1926fde0fe3af03c9c35ab935469